Citigroup Inc
- SEC CIK
- 0000831001
- Latest filing
- Aug 3, 2026
MLTX holding history
MoonLake Immunotherapeutics in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,358
- Value
- $26.4K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,358 | $26.4K | <0.1% | −12,333−90.1% | Reduced | Holders |
| Q1 2026 | 13,691 | $255.2K | <0.1% | +12,781+1,404.5% | Added | Holders |
| Q4 2025 | 910 | $12.0K | <0.1% | −7,111−88.7% | Reduced | Holders |
| Q3 2025 | 8,021 | $57.5K | <0.1% | +5,050+170.0% | Added | Holders |
| Q2 2025 | 2,971 | $140.2K | <0.1% | −18,257−86.0% | Reduced | Holders |
| Q1 2025 | 21,228 | $829.4K | <0.1% | +20,016+1,651.5% | Added | Holders |
| Q4 2024 | 1,212 | $65.6K | <0.1% | +1,212 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −2,297−100.0% | Sold out | Holders |
| Q4 2023 | 2,297 | $138.7K | <0.1% | +2,265+7,078.1% | Added | Holders |
| Q3 2023 | 32 | $1.82K | <0.1% | −571−94.7% | Reduced | Holders |
| Q2 2023 | 603 | $30.8K | <0.1% | −76,673−99.2% | Reduced | Holders |
| Q1 2023 | 77,276 | $1.65M | <0.1% | −89,041−53.5% | Reduced | Holders |
| Q4 2022 | 166,317 | $1.75M | <0.1% | +7,230+4.5% | Added | Holders |
| Q3 2022 | 159,087 | $1.27M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 159,087 | $835.0K | <0.1% | +159,087 | New | Holders |